Neuroradiology 1996-05-01

A cationic polymer, Eudragit-E, as a new liquid embolic material for arteriovenous malformations.

K Yamashita, W Taki, H Iwata, H Kikuchi

Index: Neuroradiology 38 Suppl 1 , S151-6, (1996)

Full Text: HTML

Abstract

We have developed a new liquid material for embolisation of arteriovenous malformations: a mixture of methyl and butyl methacrylate, plus dimethylaminoethyl methacrylate copolymer (Eudragit-E) in a solvent consisting of ethanol and iopamidol. Upon contact with aqueous substances, Eudragit-E precipitates rapidly and forms a soft elastic sponge within 3 s, as the ethanol diffuses. In blood, the positively charged Eudragit-E aggregates the negatively charged blood elements. Transcatheter embolisation of 4 canine and 52 rat renal arteries was feasible. Histological studies revealed no acute inflammatory reaction within 1 week, but mild to moderate reactions in the subacute and chronic stages. No recanalisation was seen. Because of its unique properties and excellent thrombogenicity the Eudragit-E, mixture seems a promising embolic material.


Related Compounds

Related Articles:

Improved supersaturation and oral absorption of dutasteride by amorphous solid dispersions.

2012-01-01

[Chem. Pharm. Bull. 60(11) , 1468-73, (2012)]

Effect of aminoalkyl methacrylate copolymer E/HCl on in vivo absorption of poorly water-soluble drug.

2013-11-01

[Drug Dev. Ind. Pharm. 39(11) , 1698-705, (2013)]

Eudragit E as excipient for production of granules and tablets from Phyllanthus niruri L spray-dried extract.

2007-01-01

[AAPS PharmSciTech 8(2) , Article 34, (2007)]

Studies on gynaecological hydrophilic lactic acid preparations. Part 5: The use of Eudragit E-100 as lactic acid carrier in intravaginal tablets.

2003-04-01

[Pharmazie 58(4) , 260-2, (2003)]

Evaluation of in vitro dissolution and in vivo oral absorption of dutasteride-loaded eudragit E nanoparticles.

2013-06-01

[Drug Res. (Stuttg.) 63(6) , 326-30, (2013)]

More Articles...